Vitalhub (TSE:VHI) PT Set at C$15.00 by Stifel Nicolaus

Vitalhub (TSE:VHI) has been assigned a C$15.00 target price by equities research analysts at Stifel Nicolaus in a report released on Wednesday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ price target would suggest a potential upside of 43.27% from the company’s current price.

Other research analysts have also issued reports about the stock. TD Securities boosted their target price on shares of Vitalhub from C$15.00 to C$16.00 and gave the company a “buy” rating in a research note on Monday, August 11th. Royal Bank Of Canada set a C$15.00 price objective on Vitalhub and gave the company a “moderate buy” rating in a research report on Thursday, September 18th. National Bankshares set a C$16.00 target price on Vitalhub and gave the stock an “outperform” rating in a research report on Thursday, August 21st. Scotiabank upped their target price on Vitalhub from C$14.00 to C$14.50 and gave the stock an “outperform” rating in a research report on Friday, June 20th. Finally, Raymond James Financial boosted their target price on Vitalhub from C$14.50 to C$15.00 and gave the stock an “outperform” rating in a report on Tuesday, August 12th. Two equities research analysts have rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the stock. According to MarketBeat, Vitalhub currently has a consensus rating of “Buy” and a consensus price target of C$14.86.

Vitalhub Trading Down 2.1%

TSE:VHI opened at C$10.47 on Wednesday. The firm has a market capitalization of C$657.83 million, a PE ratio of 130.88, a price-to-earnings-growth ratio of 1.18 and a beta of 0.62. Vitalhub has a 52 week low of C$8.50 and a 52 week high of C$14.64. The stock has a 50 day moving average of C$11.83 and a 200-day moving average of C$11.34.

Insider Buying and Selling at Vitalhub

In other news, Director Danny Matlow sold 150,000 shares of the company’s stock in a transaction on Thursday, August 28th. The stock was sold at an average price of C$12.75, for a total transaction of C$1,912,500.00. Following the transaction, the director owned 520,001 shares of the company’s stock, valued at C$6,630,012.75. This represents a 22.39% decrease in their ownership of the stock. Also, Director Steve Garrington sold 20,000 shares of Vitalhub stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of C$12.90, for a total transaction of C$258,000.00. Following the sale, the director directly owned 60,000 shares of the company’s stock, valued at C$774,000. This represents a 25.00% decrease in their position. Insiders own 18.57% of the company’s stock.

Vitalhub Company Profile

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.